These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 497811

  • 1. The effect of selective lesions of brain noradrenergic systems on the development of barbiturate tolerance in rats.
    Tabakoff B, Ritzmann RF, Oltmans GA.
    Brain Res; 1979 Nov 02; 176(2):327-36. PubMed ID: 497811
    [Abstract] [Full Text] [Related]

  • 2. Brain noradrenergic systems as a prerequisite for developing tolerance to barbiturates.
    Tabakoff B, Yanai J, Ritzmann RF.
    Science; 1978 Apr 28; 200(4340):449-51. PubMed ID: 565533
    [Abstract] [Full Text] [Related]

  • 3. Role of catecholamines in the development of tolerance to barbiturates and ethanol.
    Tabakoff B, Ritzmann RF, Hoffman PL.
    Adv Exp Med Biol; 1977 Apr 28; 85B():155-68. PubMed ID: 596278
    [Abstract] [Full Text] [Related]

  • 4. Strain differences in responsiveness of norepinephrine-sensitive adenosine 3',5'-monophosphate-generating systems in rat brain slices after intraventricular administration of 6-hydroxydopamine.
    Skolnick P, Daly JW.
    Eur J Pharmacol; 1977 Jan 21; 41(2):145-52. PubMed ID: 188662
    [Abstract] [Full Text] [Related]

  • 5. Regional brain catecholamine levels and the development of hypertension in the spontaneously hypertensive rat: the effect of 6-hydroxydopamine.
    van den Buuse M, de Kloet ER, Versteeg DH, de Jong W.
    Brain Res; 1984 Jun 03; 301(2):221-9. PubMed ID: 6428702
    [Abstract] [Full Text] [Related]

  • 6. Development of ethanol tolerance not altered by 6-OHDA lesions of dorsal bundle.
    Steketee JD, Swann AC, Silverman PB.
    Pharmacol Biochem Behav; 1989 Jul 03; 33(3):729-31. PubMed ID: 2511577
    [Abstract] [Full Text] [Related]

  • 7. Effects of intraventricular injection of 6-hydroxydopamine in the developing kitten. II. On the central monoaminergic innervation.
    Bourgoin S, Adrien J, Laguzzi RF, Dolphin A, Bockaert J, Hery F, Hamon M.
    Brain Res; 1979 Jan 19; 160(3):461-78. PubMed ID: 421125
    [No Abstract] [Full Text] [Related]

  • 8. Failure of dorsal bundle lesions in rats to increase distractibility to a low intensity tone.
    Dragunow M, Laverty R.
    Pharmacol Biochem Behav; 1983 May 19; 18(5):673-5. PubMed ID: 6407033
    [Abstract] [Full Text] [Related]

  • 9. The effects of 6-hydroxydopamine on tolerance to and dependence on ethanol.
    Tabakoff B, Ritzmann RF.
    J Pharmacol Exp Ther; 1977 Nov 19; 203(2):319-31. PubMed ID: 561843
    [Abstract] [Full Text] [Related]

  • 10. Noradrenaline and conditioned reinforcement.
    Mason ST, Robbins TW.
    Behav Neural Biol; 1979 Apr 19; 25(4):523-34. PubMed ID: 464987
    [No Abstract] [Full Text] [Related]

  • 11. Unilateral blockade of the dorsal ascending noradrenergic bundle and septal elicitation of hippocampal theta rhythm.
    McNaughton N, Kelly PH, Gray JA.
    Neurosci Lett; 1980 May 15; 18(1):67-72. PubMed ID: 6820484
    [Abstract] [Full Text] [Related]

  • 12. Effects of chlordiazepoxide on footshock- and corticotropin-releasing factor-induced increases in cortical and hypothalamic norepinephrine secretion in rats.
    Swiergiel AH, Li Y, Wei ZY, Dunn AJ.
    Neurochem Int; 2008 May 15; 52(6):1220-5. PubMed ID: 18280616
    [Abstract] [Full Text] [Related]

  • 13. Overeating and obesity from damage to a noradrenergic system in the brain.
    Ahlskog JE, Hoebel BG.
    Science; 1973 Oct 12; 182(4108):166-9. PubMed ID: 4517136
    [Abstract] [Full Text] [Related]

  • 14. Induction of tolerance to and physical dependence on pentobarbital continuous intracerebroventricular administration.
    Kimura T, Miyaoka T, Saunders PA, Baker ML, Hume AS, Yamamoto I, Ho IK.
    J Pharmacol Exp Ther; 1993 Sep 12; 266(3):1300-5. PubMed ID: 8371137
    [Abstract] [Full Text] [Related]

  • 15. Are the dorsal noradrenergic bundle projections from the locus coeruleus important for neocortical or hippocampal activation?
    Robinson TE, Vanderwolf CH, Pappas BA.
    Brain Res; 1977 Dec 09; 138(1):75-98. PubMed ID: 589470
    [Abstract] [Full Text] [Related]

  • 16. Modulation of the migrating myoelectric complex by brain noradrenergic systems in rats.
    Bonaz B, Martin L, Beurriand E, Manier M, Hostein J, Feuerstein C.
    Am J Physiol; 1991 Feb 09; 260(2 Pt 1):G340-5. PubMed ID: 1899972
    [Abstract] [Full Text] [Related]

  • 17. Alteration of avoidance and ingestive behavior after destruction of central catecholamine pathways with 6-hydroxydopamine.
    Cooper BR, Howard JL, Grant LD, Smith RD, Breese GR.
    Pharmacol Biochem Behav; 1974 Feb 09; 2(5):639-49. PubMed ID: 4610593
    [No Abstract] [Full Text] [Related]

  • 18. Catecholamines and convulsions.
    Mason ST, Corcoran ME.
    Brain Res; 1979 Jul 20; 170(3):497-507. PubMed ID: 466425
    [Abstract] [Full Text] [Related]

  • 19. Facilitation of memory consolidation by vasopressin: mediation by terminals of the dorsal noradrenergic bundle?
    Kovács GL, Bohus B, Versteeg DH.
    Brain Res; 1979 Aug 17; 172(1):73-85. PubMed ID: 466468
    [Abstract] [Full Text] [Related]

  • 20. Dopaminergic control of the septal-hippocampal cholinergic pathway.
    Robinson SE, Malthe-Sørenssen D, Wood PL, Commissiong J.
    J Pharmacol Exp Ther; 1979 Mar 17; 208(3):476-9. PubMed ID: 430364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.